Skip to content

Drug interactions

Apalutamide + Netupitant-palonosetron

Severity: Major

Apalutamide and Netupitant-palonosetron: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Apalutamide is a strong CYP3A4 inducer and can substantially reduce netupitant exposure, which relies on CYP3A4 for clearance. This may reduce antiemetic efficacy and risk breakthrough nausea and vomiting.

What this interaction means in plain words

Apalutamide and Netupitant-palonosetron can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Apalutamide belongs to Endocrine; Netupitant-palonosetron belongs to Gastrointestinal Tract.

Evidence level: Moderate

Why it happens

CYP3A4 induction by apalutamide increases netupitant metabolism and lowers its concentrations.

What to do

Avoid the combination where possible and use an alternative antiemetic regimen. If co-used, monitor for loss of antiemetic control.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Apalutamide and Netupitant-palonosetron, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Apalutamide with Netupitant-palonosetron?

MediHelp rates the interaction as major. Apalutamide and Netupitant-palonosetron can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Apalutamide is a strong CYP3A4 inducer and can substantially reduce netupitant exposure, which relies on CYP3A4 for clearance. This may reduce antiemetic efficacy and risk breakthrough nausea and vomiting.

How serious is the interaction between Apalutamide and Netupitant-palonosetron?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination where possible and use an alternative antiemetic regimen. If co-used, monitor for loss of antiemetic control.

What other medicines interact with Netupitant-palonosetron?

MediHelp also lists interactions of Netupitant-palonosetron with, for example, Apomorphine, Flibanserin, Avapritinib. The full list is on the Netupitant-palonosetron page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in